Chanrx Corp. moved a step closer to the goal line for lead candidate vanoxerine (GBR-12909), reporting Phase IIb data at the American Heart Association (AHA) 2013 Scientific Sessions suggesting the ...
RESTORE SR to study efficacy and safety of vanoxerine in atrial fibrillation (AF) and atrial flutter (AFL) patients, results expected in the second half of 2016 LA JOLLA, Calif., Laguna ...
An obese man aged 41 years presented to his internist with episodic palpitations, dyspnea and fatigue. Paroxysmal AF was diagnosed and he was treated with digoxin, verapamil and quinidine. At age 51, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback